Outset Medical (OM) News Today → Everybody laughed when he recommended Netflix (From Stansberry Research) (Ad) Free OM Stock Alerts $3.63 +0.02 (+0.55%) (As of 01:57 PM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 20 at 7:30 AM | americanbankingnews.comOutset Medical, Inc. (NASDAQ:OM) General Counsel John L. Brottem Sells 2,972 SharesMay 20 at 6:56 AM | americanbankingnews.comInsider Selling: Outset Medical, Inc. (NASDAQ:OM) CEO Sells 5,237 Shares of StockMay 20 at 6:56 AM | americanbankingnews.comOutset Medical, Inc. (NASDAQ:OM) CFO Sells $13,830.54 in StockMay 18 at 11:01 AM | insidertrades.comInsider Selling: Outset Medical, Inc. (NASDAQ:OM) General Counsel Sells 2,972 Shares of StockMay 13, 2024 | americanbankingnews.comOutset Medical, Inc. (NASDAQ:OM) CTO Sells $27,160.62 in StockMay 12, 2024 | finance.yahoo.comAnalysts Are Updating Their Outset Medical, Inc. (NASDAQ:OM) Estimates After Its First-Quarter ResultsMay 11, 2024 | insidertrades.comOutset Medical, Inc. (NASDAQ:OM) CTO Jean-Olivier Racine Sells 8,306 SharesMay 10, 2024 | marketbeat.comInsider Selling: Outset Medical, Inc. (NASDAQ:OM) CTO Sells 8,306 Shares of StockOutset Medical, Inc. (NASDAQ:OM - Get Free Report) CTO Jean-Olivier Racine sold 8,306 shares of the business's stock in a transaction that occurred on Friday, May 10th. The stock was sold at an average price of $3.27, for a total value of $27,160.62. Following the transaction, the chief technology officer now directly owns 265,325 shares in the company, valued at $867,612.75. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link.May 10, 2024 | finance.yahoo.comOutset Medical Inc (OM) Q1 2024 Earnings: Misses Revenue Estimates and Widens LossesMay 9, 2024 | markets.businessinsider.comRBC Capital Keeps Their Hold Rating on Outset Medical (OM)May 9, 2024 | finance.yahoo.comOutset Medical, Inc. (NASDAQ:OM) Q1 2024 Earnings Call TranscriptMay 9, 2024 | finance.yahoo.comOutset Medical Inc (OM) (Q1 2024) Earnings Call Transcript Highlights: Navigating Challenges ...May 9, 2024 | finance.yahoo.comOutset Medical First Quarter 2024 Earnings: US$0.79 loss per share (vs US$0.90 loss in 1Q 2023)May 8, 2024 | finance.yahoo.comOutset Medical Reports First Quarter 2024 Financial ResultsMay 8, 2024 | msn.comOutset Medical Non-GAAP EPS of -$0.57 misses by $0.02, revenue of $28.2M misses by $2.15MMay 8, 2024 | msn.comOM Stock Earnings: Outset Medical Misses EPS, Misses Revenue for Q1 2024May 6, 2024 | marketwatch.comOutset Medical Shares Rise 56% After FDA Grants Clearance for TabloCartMay 6, 2024 | msn.comWhy Outset Medical Shares Are Up TodayMay 6, 2024 | msn.comOutset Medical stock rallies 40% on FDA clearance of dialysis deviceMay 6, 2024 | markets.businessinsider.comWhy Outset Medical Is Rising In Pre-market?May 6, 2024 | businesswire.comOutset Medical's TabloCart with Prefiltration Receives FDA 510(k) ClearanceMay 1, 2024 | businesswire.comOutset Medical to Present at Upcoming Investor ConferencesMay 1, 2024 | marketbeat.comOutset Medical (OM) Scheduled to Post Quarterly Earnings on WednesdayOutset Medical (NASDAQ:OM) will be releasing earnings after the market closes on Wednesday, May 8, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=586754)April 19, 2024 | finance.yahoo.comOutset Medical to Report First Quarter 2024 Financial Results on Wednesday, May 8, 2024April 17, 2024 | finance.yahoo.comOutset Medical and U.S. Renal Care Announce Multi-Year Agreement to Accelerate and Grow Home Dialysis Across the U.S.April 17, 2024 | businesswire.comOutset Medical and U.S. Renal Care Announce Multi-Year Agreement to Accelerate and Grow Home Dialysis Across the U.S.April 15, 2024 | businesswire.comOutset Medical Partners with American Nephrology Nurses Association to Support Nephrology Nursing and Patient CareApril 9, 2024 | investing.comOutset Medical shares get Buy rating from BTIGApril 8, 2024 | msn.comBuy Rating And Bullish Price Target Sends Small Cap SoaringApril 8, 2024 | markets.businessinsider.comOutset Medical: Overcoming Challenges with Strong Market Potential and Recurring Revenue GrowthApril 8, 2024 | marketbeat.comBTIG Research Initiates Coverage on Outset Medical (NASDAQ:OM)BTIG Research initiated coverage on Outset Medical in a research note on Monday. They issued a "buy" rating and a $6.00 price objective on the stock.April 5, 2024 | marketbeat.comOutset Medical (NASDAQ:OM) Upgraded to "Buy" at CL KingCL King upgraded Outset Medical from a "neutral" rating to a "buy" rating and set a $6.00 target price on the stock in a research note on Friday.March 18, 2024 | msn.comCare Plan Your Doctor Would Usually Recommend For Acute Otitis MediaMarch 13, 2024 | businesswire.comOutset Medical Announces Appointment of Medical Technology Veteran Brent D. Lang to its Board of DirectorsMarch 11, 2024 | marketbeat.comOutset Medical, Inc. (NASDAQ:OM) Receives Average Rating of "Hold" from AnalystsOutset Medical, Inc. (NASDAQ:OM - Get Free Report) has been assigned a consensus recommendation of "Hold" from the five brokerages that are currently covering the company, MarketBeat.com reports. One equities research analyst has rated the stock with a sell rating, three have issued a hold ratingMarch 6, 2024 | wsj.comWhy Dialysis Stocks Are up TodayMarch 1, 2024 | marketbeat.comOutset Medical, Inc. (NASDAQ:OM) Shares Acquired by Braidwell LPBraidwell LP grew its holdings in Outset Medical, Inc. (NASDAQ:OM - Free Report) by 64.4% in the third quarter, according to its most recent disclosure with the SEC. The fund owned 2,400,427 shares of the company's stock after buying an additional 940,059 shares during the period. Braidwell LP owneFebruary 26, 2024 | businesswire.comOutset Medical to Present at the 44th Annual TD Cowen Health Care ConferenceFebruary 23, 2024 | finance.yahoo.comOutset Medical Full Year 2023 Earnings: EPS Misses ExpectationsFebruary 22, 2024 | markets.businessinsider.comAnalysts Have Conflicting Sentiments on These Healthcare Companies: Crispr Therapeutics AG (CRSP), Alcon (ALC) and Outset Medical (OM)February 22, 2024 | finance.yahoo.comOutset Medical, Inc. (NASDAQ:OM) Q4 2023 Earnings Call TranscriptFebruary 22, 2024 | finance.yahoo.comQ4 2023 Outset Medical Inc Earnings CallFebruary 21, 2024 | msn.comOutset Medical beats top-line and bottom-line estimates; reaffirms FY24 outlookFebruary 21, 2024 | finance.yahoo.comOutset Medical Reports Fourth Quarter and Full Year 2023 Financial ResultsFebruary 21, 2024 | finance.yahoo.comOutset Medical Inc (OM) Reports Mixed Q4 and Full Year 2023 ResultsFebruary 21, 2024 | businesswire.comOutset Medical Reports Fourth Quarter and Full Year 2023 Financial ResultsFebruary 20, 2024 | msn.comOutset Medical Q4 2023 Earnings PreviewFebruary 17, 2024 | finance.yahoo.comOM Mar 2024 4.000 putFebruary 16, 2024 | marketbeat.comInsider Selling: Outset Medical, Inc. (NASDAQ:OM) General Counsel Sells 3,341 Shares of StockOutset Medical, Inc. (NASDAQ:OM - Get Free Report) General Counsel John L. Brottem sold 3,341 shares of the firm's stock in a transaction that occurred on Thursday, February 15th. The stock was sold at an average price of $3.57, for a total transaction of $11,927.37. Following the sale, the general counsel now owns 245,046 shares in the company, valued at approximately $874,814.22. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink.February 15, 2024 | marketbeat.comOutset Medical, Inc. (NASDAQ:OM) Given Average Recommendation of "Hold" by BrokeragesOutset Medical, Inc. (NASDAQ:OM - Get Free Report) has received an average recommendation of "Hold" from the five brokerages that are currently covering the company, MarketBeat.com reports. One analyst has rated the stock with a sell rating, three have issued a hold rating and one has issued a Get Outset Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for OM and its competitors with MarketBeat's FREE daily newsletter. Email Address Everybody laughed when he recommended Netflix (Ad)"This Could be Worth Even More than A.I." Whitney Tilson's nailed many of the most famous stocks of the last 25 years – including Netflix, Amazon, and Apple. Now he's pounding the table on a new technology rolling out across America, which early estimates say could create more wealth than A.I., the personal computer, and the smartphone combined. Click here to see how it could become the No. 1 investment of the next decade. OM Media Mentions By Week OM Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. OM News Sentiment▼-0.110.42▲Average Medical News Sentiment OM News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. OM Articles This Week▼82▲OM Articles Average Week Get Outset Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for OM and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: SMLR News Today ELMD News Today AXGN News Today EDAP News Today FONR News Today VANI News Today HYPR News Today ZYXI News Today CGEN News Today HITI News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:OM) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldDoes this make you sick?Allegiance GoldDems have chosen Biden replacement?Paradigm PressThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaThis Apple-like Innovator is Revolutionizing HealthcareWall Street Star**Breaking News** LIttle Known Biotech Company Does $41 Million In Q1! Huge AlertsThis Could be Your “Big Money” AI MomentInvestorPlaceDigitizing the $11T commodities sector with one tiny stockResource Stock Digest Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Outset Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
